1. Home
  2. BEAT vs NRT Comparison

BEAT vs NRT Comparison

Compare BEAT & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAT
  • NRT
  • Stock Information
  • Founded
  • BEAT 2015
  • NRT 1975
  • Country
  • BEAT United States
  • NRT United States
  • Employees
  • BEAT N/A
  • NRT N/A
  • Industry
  • BEAT Retail: Computer Software & Peripheral Equipment
  • NRT Oil & Gas Production
  • Sector
  • BEAT Technology
  • NRT Energy
  • Exchange
  • BEAT Nasdaq
  • NRT Nasdaq
  • Market Cap
  • BEAT 63.5M
  • NRT 50.9M
  • IPO Year
  • BEAT 2021
  • NRT N/A
  • Fundamental
  • Price
  • BEAT $1.56
  • NRT $6.24
  • Analyst Decision
  • BEAT Buy
  • NRT
  • Analyst Count
  • BEAT 1
  • NRT 0
  • Target Price
  • BEAT $8.00
  • NRT N/A
  • AVG Volume (30 Days)
  • BEAT 86.1K
  • NRT 72.7K
  • Earning Date
  • BEAT 11-13-2025
  • NRT 12-30-2025
  • Dividend Yield
  • BEAT N/A
  • NRT 7.86%
  • EPS Growth
  • BEAT N/A
  • NRT 24.05
  • EPS
  • BEAT N/A
  • NRT 0.59
  • Revenue
  • BEAT N/A
  • NRT $6,184,173.00
  • Revenue This Year
  • BEAT N/A
  • NRT N/A
  • Revenue Next Year
  • BEAT $28.23
  • NRT N/A
  • P/E Ratio
  • BEAT N/A
  • NRT $10.42
  • Revenue Growth
  • BEAT N/A
  • NRT 18.55
  • 52 Week Low
  • BEAT $0.91
  • NRT $3.88
  • 52 Week High
  • BEAT $3.48
  • NRT $6.95
  • Technical
  • Relative Strength Index (RSI)
  • BEAT 44.23
  • NRT 55.38
  • Support Level
  • BEAT $1.62
  • NRT $5.95
  • Resistance Level
  • BEAT $1.74
  • NRT $6.95
  • Average True Range (ATR)
  • BEAT 0.13
  • NRT 0.34
  • MACD
  • BEAT -0.01
  • NRT 0.03
  • Stochastic Oscillator
  • BEAT 30.88
  • NRT 54.25

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks: